Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.

IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy

1982 • 272 citations

Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas

1987 • 244 citations

High-dose cisplatin in hypertonic saline in refractory ovarian cancer.

1985 • 225 citations

Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma.

1989 • 127 citations

Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy.

1987 • 111 citations

Second trial drugs in ovarian cancer

1977 • 88 citations

Ifosfamide: an active drug in the treatment of adenocarcinoma of the pancreas.

1985 • 63 citations

Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma

1981 • 58 citations

[Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].

1976 • 17 citations

Ifosfamide treatment of advanced ovarian cancer.

1984 • 14 citations